Breast cancer risk reduced in women with diabetes who take low-dose aspirin

Breast cancer risk reduced in women with diabetes who take low-dose aspirin
Credit: Mary Ann Liebert, Inc., publishers

A new study of nearly 149,000 women with diabetes over 14 years showed an overall 18% reduced breast cancer risk for women who used low-dose aspirin compared to those who did not. The study design and results are published in an article in Journal of Women's Health.

In the article entitled "Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan," Yi-Sun Yang, MD, PhD, Chien-Ning Huang, MD, PhD, and coauthors from Chung Shan Medical University Hospital and Hung Kuang University, Taichung, Taiwan, defined low-dose aspirin use as intake of 75-165 mg daily. The researchers reported that a high cumulative dose of aspirin over the 14-year study period reduced by 47%, whereas low and medium cumulative doses did not reduce risk.

"Women with type 2 diabetes have an increased risk of breast cancer, and these results suggest that the same low-dose aspirin that many of these take to prevent cardiovascular disease may also help reduce their risk of breast cancer," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.


Explore further

Researchers find regular use of aspirin can lower risk of breast cancer for women

More information: Yi-Sun Yang et al, Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan, Journal of Women's Health (2017). DOI: 10.1089/jwh.2016.6040
Journal information: Journal of Women's Health

Citation: Breast cancer risk reduced in women with diabetes who take low-dose aspirin (2017, June 8) retrieved 19 September 2019 from https://medicalxpress.com/news/2017-06-breast-cancer-women-diabetes-low-dose.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more